Mark J. Gergen
2015 - Mirati Therapeutics
In 2015, Mark J. Gergen earned a total compensation of $1.1M as Former Executive Vice President and Chief Operations Officer at Mirati Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $134,800 |
|---|---|
| Option Awards | $525,600 |
| Salary | $396,286 |
| Other | $2,814 |
| Total | $1,059,500 |
Gergen received $525.6K in option awards, accounting for 50% of the total pay in 2015.
Gergen also received $134.8K in non-equity incentive plan, $396.3K in salary and $2.8K in other compensation.
Rankings
In 2015, Mark J. Gergen's compensation ranked 7,670th out of 13,638 executives tracked by ExecPay. In other words, Gergen earned more than 43.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,670 out of 13,638 | 44th |
Division Manufacturing | 2,905 out of 5,190 | 44th |
Major group Chemicals And Allied Products | 1,050 out of 1,854 | 43rd |
Industry group Drugs | 847 out of 1,528 | 45th |
Industry Pharmaceutical Preparations | 667 out of 1,182 | 44th |
Source: SEC filing on April 20, 2017.
Gergen's colleagues
We found three more compensation records of executives who worked with Mark J. Gergen at Mirati Therapeutics in 2015.